Trial Profile
Effect of Combination Treatment with Pegvisomant and Somatostatin Analogues on the Expression of Somatostatin Receptors in Patients with Growth Hormone Secreting Pituitary Adenomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2018
Price :
$35
*
At a glance
- Drugs Pegvisomant (Primary) ; Somatostatins (Primary)
- Indications Acromegaly; Pituitary adenoma
- Focus Pharmacodynamics
- 24 Aug 2015 New trial record